RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by M. Veena N. Rao and Shyam Reddy.
Connection Strength

3.388
  1. Rao VN, Shao N, Ahmad M, Reddy ES. Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts. Oncogene. 1996 Feb 01; 12(3):523-8.
    View in: PubMed
    Score: 0.138
  2. Fang J, Xu H, Yang C, Morsalin S, Kayarthodi S, Rungsrisuriyachai K, Gunnal U, Mckenzie B, Rao VN, Reddy ES. Ets Related Gene and Smad3 Proteins Collaborate to Activate Transforming Growth Factor-Beta Mediated Signaling Pathway in ETS Related Gene-Positive Prostate Cancer Cells. J Pharm Sci Pharmacol. 2014 Sep 01; 1(3):175-181.
    View in: PubMed
    Score: 0.125
  3. Rao VN, Reddy ES. elk-1 proteins interact with MAP kinases. Oncogene. 1994 Jul; 9(7):1855-60.
    View in: PubMed
    Score: 0.124
  4. Kayarthodi S, Fujimura Y, Fang J, Morsalin S, Rao VN, Reddy ES. Anti-Epileptic Drug Targets Ewing Sarcoma. J Pharm Sci Pharmacol. 2014 Jun 01; 1(2):87-100.
    View in: PubMed
    Score: 0.123
  5. Fang J, Xu H, Yang C, Kayarthodi S, Matthews R, Rao VN, Reddy ES. Molecular Mechanism of Activation of Transforming Growth Factor Beta/Smads Signaling Pathway in Ets Related Gene-Positive Prostate Cancers. J Pharm Sci Pharmacol. 2014 Mar; 1(1):82-85.
    View in: PubMed
    Score: 0.121
  6. Xu J, Agyemang S, Qin Y, Aysola K, Giles M, Oprea G, O'Regan RM, Partridge EE, Harris-Hooker S, Rice VM, Reddy ES, Rao VN. A Novel Pathway that Links Caveolin-1 Down-Regulation to BRCA1 Dysfunction in Serous Epithelial Ovarian Cancer Cells. Enliven Chall Cancer Detect Ther. 2014; 1(1).
    View in: PubMed
    Score: 0.119
  7. Rao VN, Ohno T, Prasad DD, Bhattacharya G, Reddy ES. Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein. Oncogene. 1993 Aug; 8(8):2167-73.
    View in: PubMed
    Score: 0.116
  8. Rao VN, Reddy ES. Elk-1 proteins are phosphoproteins and activators of mitogen-activated protein kinase. Cancer Res. 1993 Aug 01; 53(15):3449-54.
    View in: PubMed
    Score: 0.116
  9. Rao VN, Reddy ES. Delta elk-1, a variant of elk-1, fails to interact with the serum response factor and binds to DNA with modulated specificity. Cancer Res. 1993 Jan 15; 53(2):215-20.
    View in: PubMed
    Score: 0.112
  10. Rao VN, Reddy ES. elk-1 domains responsible for autonomous DNA binding, SRE:SRF interaction and negative regulation of DNA binding. Oncogene. 1992 Nov; 7(11):2335-40.
    View in: PubMed
    Score: 0.110
  11. Qin Y, Xu J, Aysola K, Oprea G, Reddy A, Matthews R, Okoli J, Cantor A, Grizzle WE, Partridge EE, Reddy ES, Landen C, Rao VN. BRCA1 proteins regulate growth of ovarian cancer cells by tethering Ubc9. Am J Cancer Res. 2012; 2(5):540-8.
    View in: PubMed
    Score: 0.109
  12. Rao VN, Reddy ES. A divergent ets-related protein, elk-1, recognizes similar c-ets-1 proto-oncogene target sequences and acts as a transcriptional activator. Oncogene. 1992 Jan; 7(1):65-70.
    View in: PubMed
    Score: 0.104
  13. Reddy ES, Rao VN. erg, an ets-related gene, codes for sequence-specific transcriptional activators. Oncogene. 1991 Dec; 6(12):2285-9.
    View in: PubMed
    Score: 0.103
  14. Qin Y, Xu J, Aysola K, Begum N, Reddy V, Chai Y, Grizzle WE, Partridge EE, Reddy ES, Rao VN. Ubc9 mediates nuclear localization and growth suppression of BRCA1 and BRCA1a proteins. J Cell Physiol. 2011 Dec; 226(12):3355-67.
    View in: PubMed
    Score: 0.103
  15. Fortson WS, Kayarthodi S, Fujimura Y, Xu H, Matthews R, Grizzle WE, Rao VN, Bhat GK, Reddy ES. Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells. Int J Oncol. 2011 Jul; 39(1):111-9.
    View in: PubMed
    Score: 0.099
  16. Reddy ES, Rao VN. Localization and modulation of the DNA-binding activity of the human c-ets-1 protooncogene. Cancer Res. 1990 Aug 15; 50(16):5013-6.
    View in: PubMed
    Score: 0.094
  17. Siddique H, Rao VN, Reddy ES. CBP-mediated post-translational N-glycosylation of BRCA2. Int J Oncol. 2009 Aug; 35(2):387-91.
    View in: PubMed
    Score: 0.088
  18. Maniccia AW, Lewis C, Begum N, Xu J, Cui J, Chipitsyna G, Aysola K, Reddy V, Bhat G, Fujimura Y, Henderson B, Reddy ES, Rao VN. Mitochondrial localization, ELK-1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins. J Cell Physiol. 2009 Jun; 219(3):634-41.
    View in: PubMed
    Score: 0.087
  19. Rao VN, Huebner K, Isobe M, ar-Rushdi A, Croce CM, Reddy ES. elk, tissue-specific ets-related genes on chromosomes X and 14 near translocation breakpoints. Science. 1989 Apr 07; 244(4900):66-70.
    View in: PubMed
    Score: 0.086
  20. Xu J, Watkins T, Reddy A, Reddy ES, Rao VN. A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells. Int J Oncol. 2009 Apr; 34(4):939-49.
    View in: PubMed
    Score: 0.086
  21. Rao VN, Modi WS, Drabkin HD, Patterson D, O'Brien SJ, Papas TS, Reddy ES. The human erg gene maps to chromosome 21, band q22: relationship to the 8; 21 translocation of acute myelogenous leukemia. Oncogene. 1988 Nov; 3(5):497-500.
    View in: PubMed
    Score: 0.083
  22. Reddy ES, Rao VN. Structure, expression and alternative splicing of the human c-ets-1 proto-oncogene. Oncogene Res. 1988; 3(3):239-46.
    View in: PubMed
    Score: 0.079
  23. Rao VN, Papas TS, Reddy ES. erg, a human ets-related gene on chromosome 21: alternative splicing, polyadenylation, and translation. Science. 1987 Aug 07; 237(4815):635-9.
    View in: PubMed
    Score: 0.077
  24. Yuli C, Shao N, Rao R, Aysola P, Reddy V, Oprea-llies G, Lee L, Okoli J, Partridge E, Reddy ES, Rao VN. BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers. Oncogene. 2007 Sep 06; 26(41):6031-7.
    View in: PubMed
    Score: 0.075
  25. Rao VN, Zweig M, Papas TS, Reddy ES. Expression in E. coli of erg: a novel gene in humans related to the ets oncogene. Oncogene Res. 1987; 2(1):95-101.
    View in: PubMed
    Score: 0.074
  26. Ramakrishnan R, Fujimura Y, Zou JP, Liu F, Lee L, Rao VN, Reddy ES. Role of protein-protein interactions in the antiapoptotic function of EWS-Fli-1. Oncogene. 2004 Sep 16; 23(42):7087-94.
    View in: PubMed
    Score: 0.063
  27. Fujimura Y, Siddique H, Lee L, Rao VN, Reddy ES. EWS-ATF-1 chimeric protein in soft tissue clear cell sarcoma associates with CREB-binding protein and interferes with p53-mediated trans-activation function. Oncogene. 2001 Oct 11; 20(46):6653-9.
    View in: PubMed
    Score: 0.051
  28. Chai Y, Chipitsyna G, Cui J, Liao B, Liu S, Aysola K, Yezdani M, Reddy ES, Rao VN. c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells. Oncogene. 2001 Mar 15; 20(11):1357-67.
    View in: PubMed
    Score: 0.049
  29. Zou JP, Hirose Y, Siddique H, Rao VN, Reddy ES. Structure and expression of variant BRCA2a lacking the transactivation domain. Oncol Rep. 1999 Mar-Apr; 6(2):437-40.
    View in: PubMed
    Score: 0.043
  30. Dhulipala PD, Lee L, Rao VN, Reddy ES. Fli-1b is generated by usage of differential splicing and alternative promoter. Oncogene. 1998 Sep 03; 17(9):1149-57.
    View in: PubMed
    Score: 0.041
  31. Shao N, Chai Y, Cui JQ, Wang N, Aysola K, Reddy ES, Rao VN. Induction of apoptosis by Elk-1 and deltaElk-1 proteins. Oncogene. 1998 Jul 30; 17(4):527-32.
    View in: PubMed
    Score: 0.041
  32. Cui JQ, Wang H, Reddy ES, Rao VN. Differential transcriptional activation by the N-terminal region of BRCA1 splice variants BRCA1a and BRCA1b. Oncol Rep. 1998 May-Jun; 5(3):585-9.
    View in: PubMed
    Score: 0.040
  33. Cui JQ, Shao N, Chai Y, Wang H, Reddy ES, Rao VN. BRCA1 splice variants BRCA1a and BRCA1b associate with CBP co-activator. Oncol Rep. 1998 May-Jun; 5(3):591-5.
    View in: PubMed
    Score: 0.040
  34. Siddique H, Zou JP, Rao VN, Reddy ES. The BRCA2 is a histone acetyltransferase. Oncogene. 1998 Apr 30; 16(17):2283-5.
    View in: PubMed
    Score: 0.040
  35. Wang H, Shao N, Ding QM, Cui J, Reddy ES, Rao VN. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Oncogene. 1997 Jul 10; 15(2):143-57.
    View in: PubMed
    Score: 0.038
  36. Yi H, Fujimura Y, Ouchida M, Prasad DD, Rao VN, Reddy ES. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias. Oncogene. 1997 Mar 20; 14(11):1259-68.
    View in: PubMed
    Score: 0.037
  37. Fujimura Y, Ohno T, Siddique H, Lee L, Rao VN, Reddy ES. The EWS-ATF-1 gene involved in malignant melanoma of soft parts with t(12;22) chromosome translocation, encodes a constitutive transcriptional activator. Oncogene. 1996 Jan 04; 12(1):159-67.
    View in: PubMed
    Score: 0.034
  38. Ouchida M, Ohno T, Fujimura Y, Rao VN, Reddy ES. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts. Oncogene. 1995 Sep 21; 11(6):1049-54.
    View in: PubMed
    Score: 0.034
  39. Prasad DD, Ouchida M, Lee L, Rao VN, Reddy ES. TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. Oncogene. 1994 Dec; 9(12):3717-29.
    View in: PubMed
    Score: 0.032
  40. Ohno T, Ouchida M, Lee L, Gatalica Z, Rao VN, Reddy ES. The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene. 1994 Oct; 9(10):3087-97.
    View in: PubMed
    Score: 0.031
  41. Prasad DD, Rao VN, Lee L, Reddy ES. Differentially spliced erg-3 product functions as a transcriptional activator. Oncogene. 1994 Feb; 9(2):669-73.
    View in: PubMed
    Score: 0.030
  42. Ohno T, Rao VN, Reddy ES. EWS/Fli-1 chimeric protein is a transcriptional activator. Cancer Res. 1993 Dec 15; 53(24):5859-63.
    View in: PubMed
    Score: 0.030
  43. Bhattacharya G, Lee L, Reddy ES, Rao VN. Transcriptional activation domains of elk-1, delta elk-1 and SAP-1 proteins. Oncogene. 1993 Dec; 8(12):3459-64.
    View in: PubMed
    Score: 0.030
  44. Siddique HR, Rao VN, Lee L, Reddy ES. Characterization of the DNA binding and transcriptional activation domains of the erg protein. Oncogene. 1993 Jul; 8(7):1751-5.
    View in: PubMed
    Score: 0.029
  45. Prasad DD, Rao VN, Reddy ES. Structure and expression of human Fli-1 gene. Cancer Res. 1992 Oct 15; 52(20):5833-7.
    View in: PubMed
    Score: 0.027
  46. Dudek H, Tantravahi RV, Rao VN, Reddy ES, Reddy EP. Myb and Ets proteins cooperate in transcriptional activation of the mim-1 promoter. Proc Natl Acad Sci U S A. 1992 Feb 15; 89(4):1291-5.
    View in: PubMed
    Score: 0.026
  47. Reddy ES, Rao VN, Papas TS. The erg gene: a human gene related to the ets oncogene. Proc Natl Acad Sci U S A. 1987 Sep; 84(17):6131-5.
    View in: PubMed
    Score: 0.019
  48. Rao VN, Reddy ES, Torriani A, Bhargava PM. Seminalplasmin inhibits transcription and translation of phi80 DNA in vitro. FEBS Lett. 1983 Feb 07; 152(1):6-10.
    View in: PubMed
    Score: 0.014
  49. Pereira DS, Dorrell C, Ito CY, Gan OI, Murdoch B, Rao VN, Zou JP, Reddy ES, Dick JE. Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells. Proc Natl Acad Sci U S A. 1998 Jul 07; 95(14):8239-44.
    View in: PubMed
    Score: 0.010
  50. Hipskind RA, Rao VN, Mueller CG, Reddy ES, Nordheim A. Ets-related protein Elk-1 is homologous to the c-fos regulatory factor p62TCF. Nature. 1991 Dec 19-26; 354(6354):531-4.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support